Comparison of the Effect of Fimasartan versus Valsartan on Blood Pressure Variability in Acute Ischemic Stroke: A Double-Blind Randomized Trial

Table 2

BPV-the other parameters.

	Initial			8 weeks after
S.D.	Valsartan	Fimasartan	P-value	Valsartan	Fimasartan	P-value
24-h SBP wSD	8.88±3.55	10.26±3.19	.118	10.77±4.18	8.27±3.01	.010
24-h DBP wSD	6.74±2.82	7.29±2.91	.457	7.84±2.71	6.82±2.72	.148
24-h SBP CV	10.95±4.50	13.76±4.25	.016	15.51±6.91	13.47±4.21	.173
24-h DBP CV	14.24±5.48	16.58±6.09	.121	19.05±7.82	18.02±5.98	.572
24-h SBP ARV	17.77±7.01	18.23±4.20	.756	19.68±7.83	15.85±6.17	.040
24-h DBP ARV	14.20±5.79	14.15±4.60	.968	15.44±6.82	13.82±6.00	.332

Values are presented as the mean ± SD. P values were calculated using the independent t-test.